Safety and Efficacy of Triple Combination Therapy in Patients With Glaucoma or Ocular Hypertension

Exclusion Criteria

• •Other active ocular disease other than glaucoma or ocular hypertension (eg, uveitis, ocular infections or severe dry eye)
• •Current or anticipated use of ocular medications other than study medications, except for intermittent use of artificial tears
• •Use of oral, injectable or topical corticosteroids within 21 days
• •Iridectomy or laser peripheral iridotomy in the study eye within 3 months
• •Uncomplicated cataract surgery in the study eye within 6 months
• •Incisional glaucoma surgery in the study eye within 12 months